Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,815
archived clinical trials in
Parkinsons Disease

Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Consultants in Neurology, Ltd.
mi
from
Northbrook, IL
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Consultants in Neurology, Ltd.
mi
from
Northbrook, IL
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Advanced Neurology Specialists
mi
from
Great Falls, MT
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Advanced Neurology Specialists
mi
from
Great Falls, MT
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Neurological Associates, P.C.
mi
from
Lincoln, NE
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Neurological Associates, P.C.
mi
from
Lincoln, NE
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Upstate Clinical Research, LLC
mi
from
Albany, NY
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Upstate Clinical Research, LLC
mi
from
Albany, NY
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
DENT Neurologic Group L.L.P.
mi
from
Amherst, NY
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
DENT Neurologic Group L.L.P.
mi
from
Amherst, NY
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Hospital for Joint Diseases - MS Care Center
mi
from
New York, NY
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Hospital for Joint Diseases - MS Care Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Raleigh Neurology Associates
mi
from
Raleigh, NC
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Raleigh Neurology Associates
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
NeuroCare Center, Inc.
mi
from
Canton, OH
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
NeuroCare Center, Inc.
mi
from
Canton, OH
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
MetroHealth Med Ctr
mi
from
Cleveland, OH
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
University Memory and Aging Center
mi
from
Cleveland, OH
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
University Memory and Aging Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Clinical Pharmaceutical Trials, Inc.
mi
from
Tulsa, OK
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Clinical Pharmaceutical Trials, Inc.
mi
from
Tulsa, OK
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Lehigh Valley Neurosciences and Pain Research Center
mi
from
Allentown, PA
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Lehigh Valley Neurosciences and Pain Research Center
mi
from
Allentown, PA
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Westmoreland Neurology
mi
from
Greensburg, PA
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Westmoreland Neurology
mi
from
Greensburg, PA
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Clinical Research Facility
mi
from
Jenkintown, PA
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Clinical Research Facility
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
MCP Hahnemann University
mi
from
Philadelphia, PA
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
MCP Hahnemann University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Penn Neurological Institute
mi
from
Philadelphia, PA
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Penn Neurological Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Neurological Associates of Delaware Valley
mi
from
Upland, PA
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Neurological Associates of Delaware Valley
mi
from
Upland, PA
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Claghorn-Lesem Research Clinic
mi
from
Bellaire, TX
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Claghorn-Lesem Research Clinic
mi
from
Bellaire, TX
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Methodist Neurological Institute
mi
from
Houston, TX
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Methodist Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Fletcher Allen Health Care
mi
from
Burlington, VT
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
Neurology and Neurosurgery Associates of Tacoma
mi
from
Tacoma, WA
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
Neurology and Neurosurgery Associates of Tacoma
mi
from
Tacoma, WA
Click here to add this to my saved trials
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated:  7/13/2016
University of Wisconsin
mi
from
Madison, WI
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.
Status: Enrolling
Updated: 7/13/2016
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
A 12-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study of the Efficacy of Doses of 20 and 60 mg/Day Istradefylline as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa/Carbidopa
Status: Enrolling
Updated:  7/13/2016
Contact Kyowa Pharmaceutical, Inc.
mi
from
Princeton, NJ
12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
A 12-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study of the Efficacy of Doses of 20 and 60 mg/Day Istradefylline as Treatment for Parkinson's Disease in Patients With Motor Response Complications on Levodopa/Carbidopa
Status: Enrolling
Updated: 7/13/2016
Contact Kyowa Pharmaceutical, Inc.
mi
from
Princeton, NJ
Click here to add this to my saved trials
Video Based Mindfulness Based Stress Reduction
Video Based Mindfulness Based Stress Reduction
Status: Enrolling
Updated:  8/1/2016
Oregon Health and Science University
mi
from
Portland, OR
Video Based Mindfulness Based Stress Reduction
Video Based Mindfulness Based Stress Reduction
Status: Enrolling
Updated: 8/1/2016
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Video Based Mindfulness Based Stress Reduction
Video Based Mindfulness Based Stress Reduction
Status: Enrolling
Updated:  8/1/2016
VA Portland Health Care System
mi
from
Portland, OR
Video Based Mindfulness Based Stress Reduction
Video Based Mindfulness Based Stress Reduction
Status: Enrolling
Updated: 8/1/2016
VA Portland Health Care System
mi
from
Portland, OR
Click here to add this to my saved trials
Tai Chi for Enhancing Motor and Cognitive Function in Parkinson's Disease
Tai Chi for Enhancing Motor and Cognitive Function in Parkinson's Disease
Status: Enrolling
Updated:  8/18/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Tai Chi for Enhancing Motor and Cognitive Function in Parkinson's Disease
Tai Chi for Enhancing Motor and Cognitive Function in Parkinson's Disease
Status: Enrolling
Updated: 8/18/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Status: Enrolling
Updated:  11/4/2016
University of Alabama
mi
from
Birmingham, AL
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Status: Enrolling
Updated: 11/4/2016
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Status: Enrolling
Updated:  11/4/2016
University of South Florida
mi
from
Tampa, FL
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Status: Enrolling
Updated: 11/4/2016
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Status: Enrolling
Updated:  11/4/2016
Rush University Medical Center
mi
from
Chicago, IL
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Status: Enrolling
Updated: 11/4/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Status: Enrolling
Updated:  11/4/2016
Duke University
mi
from
Durham, NC
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Status: Enrolling
Updated: 11/4/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Status: Enrolling
Updated:  11/4/2016
Oregon Health and Sciences University
mi
from
Portland, OR
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Status: Enrolling
Updated: 11/4/2016
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Haptoglobin and Iron in Parkinson's Disease
Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson's Disease
Status: Enrolling
Updated:  11/28/2016
University of California
mi
from
San Diego, CA
Haptoglobin and Iron in Parkinson's Disease
Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson's Disease
Status: Enrolling
Updated: 11/28/2016
University of California
mi
from
San Diego, CA
Click here to add this to my saved trials
Haptoglobin and Iron in Parkinson's Disease
Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson's Disease
Status: Enrolling
Updated:  11/28/2016
Bastyr University Research Institute
mi
from
Kenmore, WA
Haptoglobin and Iron in Parkinson's Disease
Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson's Disease
Status: Enrolling
Updated: 11/28/2016
Bastyr University Research Institute
mi
from
Kenmore, WA
Click here to add this to my saved trials
Haptoglobin and Iron in Parkinson's Disease
Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson's Disease
Status: Enrolling
Updated:  11/28/2016
Univ of Washington
mi
from
Seattle, WA
Haptoglobin and Iron in Parkinson's Disease
Haptoglobin Phenotype and Smoking: Effects on Iron Levels in Parkinson's Disease
Status: Enrolling
Updated: 11/28/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
Clinical Research Facility
mi
from
Fountain Valley, CA
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
Clinical Research Facility
mi
from
Boca Raton, FL
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
mi
from
Hallandale, FL
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
mi
from
Hallandale, FL
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
Clinical Research Facility
mi
from
Saint Petersburg, FL
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
Clinical Research Facility
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
Clinical Research Facility
mi
from
Sunrise, FL
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
Clinical Research Facility
mi
from
Tampa, FL
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
Clinical Research Facility
mi
from
Atlanta, GA
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
Clinical Research Facility
mi
from
Chicago, IL
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
Clinical Research Facility
mi
from
Farmington Hills, MI
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
Clinical Research Facility
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
Clinical Research Facility
mi
from
West Bloomfield, MI
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
Clinical Research Facility
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated:  12/14/2016
Clinical Research Facility
mi
from
Nashville, TN
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
A Phase 1 Study of the Safety and Tolerability of a Single Dose Administration of CVT- 301 (Levodopa Inhalation Powder) When Administered for Early Morning OFF Symptoms in Patients With Parkinson's Disease
Status: Enrolling
Updated: 12/14/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Clinically Diagnosed Tauopathies in Comparison to Healthy Subjects
Status: Enrolling
Updated:  12/15/2016
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Clinically Diagnosed Tauopathies in Comparison to Healthy Subjects
Status: Enrolling
Updated: 12/15/2016
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Click here to add this to my saved trials
ALTROPANE® SPECT Imaging in Patients With Parkinson Disease
Optimizing the Performance of ALTROPANE® SPECT Imaging in Patients With Parkinson Disease
Status: Enrolling
Updated:  12/15/2016
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
ALTROPANE® SPECT Imaging in Patients With Parkinson Disease
Optimizing the Performance of ALTROPANE® SPECT Imaging in Patients With Parkinson Disease
Status: Enrolling
Updated: 12/15/2016
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Click here to add this to my saved trials